Rocket Pharmaceuticals, Inc. is a leading biotechnology company headquartered in Cranbury, New Jersey, specializing in the development of innovative gene therapies for rare and life-threatening diseases. The company leverages its proprietary technology platform to create transformative treatment solutions aimed at achieving long-term cures, thereby demonstrating its commitment to advancing medicine through scientific excellence. With a diverse and promising pipeline, Rocket is well-positioned to address significant unmet medical needs and enhance patient outcomes, establishing itself as a key player in the evolving landscape of gene therapy. Show more
Location: USA | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
0.00
52 Wk Range
$0.02 - $0.02
Previous Close
$0.02
Open
$0.02
Volume
10,000
Day Range
$0.02 - $0.02
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
